{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:45:10Z","timestamp":1770741910568,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-028"],"award-info":[{"award-number":["2021-I2M-1-028"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-030"],"award-info":[{"award-number":["2021-I2M-1-030"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7222118"],"award-info":[{"award-number":["7222118"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903695"],"award-info":[{"award-number":["81903695"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.bioorg.2022.105971","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T02:07:58Z","timestamp":1655345278000},"page":"105971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Dehydromevalonolactone ameliorates liver fibrosis and inflammation by repressing activation of NLRP3 inflammasome"],"prefix":"10.1016","volume":"127","author":[{"given":"Wei-Xiao","family":"Niu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Yang","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Ning","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Xu","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bioorg.2022.105971_b0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.bioorg.2022.105971_b0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv Drug Deliv Rev."},{"issue":"6342","key":"10.1016\/j.bioorg.2022.105971_b0015","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1126\/science.aam7928","article-title":"Inflammation and metabolism in tissue repair and regeneration","volume":"356","author":"Eming","year":"2017","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.bioorg.2022.105971_b0020","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/liv.14940","article-title":"Hepatic macrophages: key players in the development and progression of liver fibrosis","volume":"41","author":"Cheng","year":"2021","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105971_b0025","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2016.05.037","article-title":"Bone marrow-derived and resident liver macrophages display unique transcriptomic signatures but similar biological functions","volume":"65","author":"Beattie","year":"2016","journal-title":"J Hepatol."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105971_b0030","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/cmi.2015.104","article-title":"Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies","volume":"13","author":"Ju","year":"2016","journal-title":"Cell Mol Immunol."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105971_b0035","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J Hepatol."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105971_b0040","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice","volume":"58","author":"Pradere","year":"2013","journal-title":"Hepatology"},{"issue":"03","key":"10.1016\/j.bioorg.2022.105971_b0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin Liver Dis."},{"issue":"10","key":"10.1016\/j.bioorg.2022.105971_b0050","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00109-014-1170-1","article-title":"NLRP3 inflammasome activation is required for fibrosis development in NAFLD","volume":"92","author":"Wree","year":"2014","journal-title":"J Mol Med (Berl)."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105971_b0055","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"issue":"7444","key":"10.1016\/j.bioorg.2022.105971_b0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bioorg.2022.105971_b0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jhep.2020.01.011","article-title":"Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure","volume":"73","author":"Engelmann","year":"2020","journal-title":"J Hepatol."},{"issue":"8","key":"10.1016\/j.bioorg.2022.105971_b0070","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat Rev Immunol."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105971_b0075","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis","volume":"74","author":"Gaul","year":"2021","journal-title":"J Hepatol."},{"key":"10.1016\/j.bioorg.2022.105971_b0080","first-page":"1505","article-title":"Advances in mechanisms for NLRP3 inflammasomes regulation","volume":"51","author":"Wen","year":"2016","journal-title":"Acta Pharmaceutica Sinica"},{"issue":"6","key":"10.1016\/j.bioorg.2022.105971_b0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.bioorg.2022.105971_b0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fcell.2020.00139","article-title":"Involvement of nucleotide-binding oligomerization domain-Like receptor family pyrin domain containing 3 inflammasome in the pathogenesis of liver diseases","volume":"8","author":"Shi","year":"2020","journal-title":"Front Cell Dev Biol."},{"key":"10.1016\/j.bioorg.2022.105971_b0095","article-title":"Inflammasomes and Fibrosis","volume":"12","author":"Zhang","year":"2021","journal-title":"Inflammasomes and fibrosis. Front Immunol."},{"issue":"12","key":"10.1016\/j.bioorg.2022.105971_b0100","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1172\/JCI12568","article-title":"Transient expression of IL-1\u03b2 induces acute lung injury and chronic repair leading to pulmonary fibrosis","volume":"107","author":"Kolb","year":"2001","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105971_b0105","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J Nat Prod."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105971_b0110","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1021\/acs.orglett.9b00385","article-title":"Isocoumarindole A, a chlorinated isocoumarin and indole alkaloid hybrid metabolite from an endolichenic fungus aspergillus sp","volume":"21","author":"Chen","year":"2019","journal-title":"Org Lett."},{"key":"10.1016\/j.bioorg.2022.105971_b0115","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/10286020.2020.1794857","article-title":"Fusapyrone A, a gamma-pyrone derived from a desert Fusarium sp","volume":"23","author":"Zhen","year":"2021","journal-title":"J Asian Nat Prod Res."},{"key":"10.1016\/j.bioorg.2022.105971_b0120","first-page":"169","article-title":"Establishment and application of a high-throughput drug screening model based on COL1A1 promoter for anti-liver fibrosis","volume":"50","author":"Zhao","year":"2015","journal-title":"Yao Xue Xue Bao."},{"issue":"4","key":"10.1016\/j.bioorg.2022.105971_b0125","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/aps.2014.155","article-title":"The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K\/Akt\/Smad pathway","volume":"36","author":"Yu","year":"2015","journal-title":"Acta Pharmacol Sin."},{"issue":"2","key":"10.1016\/j.bioorg.2022.105971_b0130","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.28965","article-title":"The ascending pathophysiology of cholestatic liver disease","volume":"65","author":"Jansen","year":"2017","journal-title":"Hepatology"},{"issue":"133","key":"10.1016\/j.bioorg.2022.105971_b0135","doi-asserted-by":"crossref","DOI":"10.3791\/56930","article-title":"Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis","author":"Yokota","year":"2018","journal-title":"J Vis Exp."},{"key":"10.1016\/j.bioorg.2022.105971_b0140","doi-asserted-by":"crossref","DOI":"10.1002\/hep.32320","article-title":"Nlrp3 activation causes spontaneous inflammation and fibrosis that mimics human NASH","author":"Calcagno","year":"2022","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.bioorg.2022.105971_b0145","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12868","article-title":"Wedelolactone facilitates Ser\/Thr phosphorylation of NLRP3 dependent on PKA signalling to block inflammasome activation and pyroptosis","volume":"53","author":"Pan","year":"2020","journal-title":"Cell Prolif."},{"issue":"33","key":"10.1016\/j.bioorg.2022.105971_b0150","doi-asserted-by":"crossref","first-page":"20167","DOI":"10.1074\/jbc.M115.652321","article-title":"Caspase-8 as an effector and regulator of NLRP3 inflammasome signaling","volume":"290","author":"Antonopoulos","year":"2015","journal-title":"J Biol Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105971_b0155","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J Hepatol."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105971_b0160","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cmet.2020.01.013","article-title":"Targeting hepatic glutaminase 1 ameliorates non-alcoholic steatohepatitis by restoring very-low-density lipoprotein triglyceride assembly","volume":"31","author":"Simon","year":"2020","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105971_b0165","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1007\/s12072-021-10210-w","article-title":"Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice","volume":"15","author":"Yang","year":"2021","journal-title":"Hepatol Int."},{"key":"10.1016\/j.bioorg.2022.105971_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.609465","article-title":"Characterization of the CDAA diet-induced non-alcoholic steatohepatitis model: sex-specific differences in inflammation, fibrosis, and cholesterol metabolism in middle-aged mice","volume":"12","author":"Kucsera","year":"2021","journal-title":"Front Physiol."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105971_b0175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat Rev Immunol."},{"issue":"5","key":"10.1016\/j.bioorg.2022.105971_b0180","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jhep.2011.09.024","article-title":"Clinical evidence for the regression of liver fibrosis","volume":"56","author":"Ellis","year":"2012","journal-title":"J Hepatol."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105971_b0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/joim.13380","article-title":"Inflammatory and fibrotic mechanisms in NAFLD-Implications for new treatment strategies","volume":"291","author":"Lee","year":"2022","journal-title":"J Intern Med."},{"issue":"1","key":"10.1016\/j.bioorg.2022.105971_b0190","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.32163","article-title":"Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases","volume":"75","author":"Gin\u00e8s","year":"2022","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bioorg.2022.105971_b0195","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jhep.2018.05.038","article-title":"Regulation of epithelial injury and bile duct obstruction by NLRP3, IL-1R1 in experimental biliary atresia","volume":"69","author":"Yang","year":"2018","journal-title":"J Hepatol."},{"issue":"3","key":"10.1016\/j.bioorg.2022.105971_b0200","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med."},{"key":"10.1016\/j.bioorg.2022.105971_b0205","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.intimp.2019.02.016","article-title":"The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice","volume":"70","author":"Qu","year":"2019","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.bioorg.2022.105971_b0210","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bioorg.2022.105971_b0215","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/hep.27680","article-title":"Nonalcoholic fatty liver disease: fibrosis portends a worse prognosis","volume":"61","author":"Torres","year":"2015","journal-title":"Hepatology"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822003765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206822003765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:35:49Z","timestamp":1758616549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206822003765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":43,"alternative-id":["S0045206822003765"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105971","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dehydromevalonolactone ameliorates liver fibrosis and inflammation by repressing activation of NLRP3 inflammasome","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2022.105971","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105971"}}